In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis

Ting Shen, Zijian Yang Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaCorrespondence: Zijian YangDepartment of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University,...

Full description

Bibliographic Details
Main Authors: Shen T, Yang Z
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/in-vivo-and-in-vitro-evaluation-of-in-situ-gel-formulation-of-pemirola-peer-reviewed-fulltext-article-DDDT
_version_ 1819070158378893312
author Shen T
Yang Z
author_facet Shen T
Yang Z
author_sort Shen T
collection DOAJ
description Ting Shen, Zijian Yang Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaCorrespondence: Zijian YangDepartment of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, No. 197 Second Ruijin Road, Shanghai, People’s Republic of ChinaEmail doctoryzj2020@163.comBackground: To establish a novel delivery system of pemirolast potassium-loaded gellan gum in situ gel in allergic conjunctivitis therapy.Methods: The prepared in situ gels were studied in the following aspects: in vitro gelation, in vitro release, stability, viscosity measurement, in vivo tear kinetics and pharmacodynamics.Results: In this study, the results showed that the viscosity of the in situ gels significantly increased when the preparation was in contact with simulated tear fluid and it also exhibited good stability in a period of three months. In vitro release showed that the release of pemirolast potassium from in situ gels had a good sustained release ability. No ocular damage or abnormal clinical signs to the cornea, iris, or conjunctivae were visible. Consistent with the in vitro studies, pemirolast potassium in situ gels were highly efficient in suppressing the inflammatory symptoms and improving the ocular bioavailability.Conclusion: Pemirolast potassium ocular in situ gels are safe and promising therapeutic alternatives to the existing medications for allergic conjunctivitis therapy.Keywords: pemirolast potassium, gellan gum, in situ gel, allergic conjunctivitis, pharmacodynamic
first_indexed 2024-12-21T17:01:29Z
format Article
id doaj.art-42015690d53444aea9916679cb6de1ff
institution Directory Open Access Journal
issn 1177-8881
language English
last_indexed 2024-12-21T17:01:29Z
publishDate 2021-05-01
publisher Dove Medical Press
record_format Article
series Drug Design, Development and Therapy
spelling doaj.art-42015690d53444aea9916679cb6de1ff2022-12-21T18:56:37ZengDove Medical PressDrug Design, Development and Therapy1177-88812021-05-01Volume 152099210764890In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic ConjunctivitisShen TYang ZTing Shen, Zijian Yang Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaCorrespondence: Zijian YangDepartment of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, No. 197 Second Ruijin Road, Shanghai, People’s Republic of ChinaEmail doctoryzj2020@163.comBackground: To establish a novel delivery system of pemirolast potassium-loaded gellan gum in situ gel in allergic conjunctivitis therapy.Methods: The prepared in situ gels were studied in the following aspects: in vitro gelation, in vitro release, stability, viscosity measurement, in vivo tear kinetics and pharmacodynamics.Results: In this study, the results showed that the viscosity of the in situ gels significantly increased when the preparation was in contact with simulated tear fluid and it also exhibited good stability in a period of three months. In vitro release showed that the release of pemirolast potassium from in situ gels had a good sustained release ability. No ocular damage or abnormal clinical signs to the cornea, iris, or conjunctivae were visible. Consistent with the in vitro studies, pemirolast potassium in situ gels were highly efficient in suppressing the inflammatory symptoms and improving the ocular bioavailability.Conclusion: Pemirolast potassium ocular in situ gels are safe and promising therapeutic alternatives to the existing medications for allergic conjunctivitis therapy.Keywords: pemirolast potassium, gellan gum, in situ gel, allergic conjunctivitis, pharmacodynamichttps://www.dovepress.com/in-vivo-and-in-vitro-evaluation-of-in-situ-gel-formulation-of-pemirola-peer-reviewed-fulltext-article-DDDTpemirolast potassiumgellan gumin situ gelallergic conjunctivitispharmacodynamic
spellingShingle Shen T
Yang Z
In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis
Drug Design, Development and Therapy
pemirolast potassium
gellan gum
in situ gel
allergic conjunctivitis
pharmacodynamic
title In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis
title_full In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis
title_fullStr In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis
title_full_unstemmed In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis
title_short In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis
title_sort in vivo and in vitro evaluation of in situ gel formulation of pemirolast potassium in allergic conjunctivitis
topic pemirolast potassium
gellan gum
in situ gel
allergic conjunctivitis
pharmacodynamic
url https://www.dovepress.com/in-vivo-and-in-vitro-evaluation-of-in-situ-gel-formulation-of-pemirola-peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT shent invivoandinvitroevaluationofinsitugelformulationofpemirolastpotassiuminallergicconjunctivitis
AT yangz invivoandinvitroevaluationofinsitugelformulationofpemirolastpotassiuminallergicconjunctivitis